文献速递眼底病与葡萄膜炎

细胞外囊泡疗法在视网膜疾病中的应用

Extracellular vesicle therapy for retinal diseases.
PubMed 文献 · Prog Retin Eye Res · 2020-03-10

本文综述细胞外囊泡(EV,含外泌体与微囊泡)因携带mRNA、miRNA、脂质和蛋白而参与细胞间通讯、疾病进展及生物标志物研究,并探讨其作为替代旁分泌型细胞疗法的潜力。视网膜是中枢神经系统易于进入的组成部分,也是多种细胞疗法的试验范式;现有研究显示向眼内递送EV/外泌体可在多种视网膜疾病模型中产生显著治疗效应。

要点

  • EV携带mRNA、miRNA、脂质和蛋白,可向邻近细胞及经血流远距离递送货物。
  • EV在细胞间通讯、疾病进展和生物标志物方面受到广泛关注。
  • 多项研究显示眼内递送EV/外泌体在多种视网膜疾病模型中产生显著治疗效应。

核心结论

  • EV/外泌体眼内递送在多种视网膜疾病模型中可产生显著治疗效应,有望替代旁分泌型细胞疗法。

研究设计与样本

  • 综述类:总结当前已发表研究的检索结果,涵盖多种眼病模型中的疗效数据。

主要发现

  • EV包含外泌体与微囊泡,几乎每种细胞均可分泌,携带mRNA、miRNA、脂质和蛋白。
  • EV可将货物递送至邻近细胞,也可经血流远距离递送。
  • 已有多项研究显示眼内递送EV/外泌体在多种视网膜疾病模型中产生显著治疗效应。

临床怎么用

  • 视网膜是中枢神经系统易于进入的组成部分,可作为细胞疗法试验范式,EV疗法有望替代旁分泌型细胞疗法。

局限性

  • 综述指出未来研究方向尚需明确,未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Extracellular vesicles (EV), which include exosomes and microvesicles, are secreted from virtually every cell. EV contain mRNA, miRNA, lipids and proteins and can deliver this expansive cargo into nearby cells as well as over long distances via the blood stream. Great interest has been given to them for their role in cell to cell communication, disease progression, or as biomarkers, and more recent studies have interrogated their potential as a therapeutic that may replace paracrine-acting cell therapies. The retina is a conveniently accessible component of the central nervous system and the proposed paradigm for the testing of many cell therapies. Recently, several studies have been published demonstrating that the delivery of EV/exosomes into the eye can elicit significant therapeutic effects in several models of retinal disease. We summarize results from currently available studies, demonstrating their efficacy in multiple eye disease models as well as highlighting where future research efforts should be directed.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Mead B, Tomarev S. Extracellular vesicle therapy for retinal diseases. Prog Retin Eye Res. 2020. PMID: 32169632. doi:10.1016/j.preteyeres.2020.100849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。